Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T cell (Treg) proliferation refers to the process by which regulatory T cells expand in number, either in the thymus during development or in peripheral tissues during immune responses. Tregs are a specialized subset of CD4+ T cells characterized by high expression of CD25 (the IL-2 receptor α chain) and the transcription factor FOXP3. Their primary function is to maintain immune homeostasis and prevent autoimmunity by suppressing the activation, proliferation, and function of effector T cells. Treg proliferation is regulated through cytokine signaling (particularly IL-2), transcriptional regulation by FOXP3, and various suppressive mechanisms including cytokine deprivation, secretion of inhibitory cytokines, direct cytolysis, metabolic disruption, and modulation via co-stimulatory molecules. The net outcome is an increased pool size capable of exerting dominant suppression over potentially pathogenic immune responses.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory T Cell Proliferation.